REPORT ID 13356

United States Microneedles for Trans / Intradermal Drug Delivery Market Report 2017

Publish Date
21-Nov-17
Pages
100
Format
Electronic (PDF)

In this report, the United States Microneedles for Trans / Intradermal Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Microneedles for Trans / Intradermal Drug Delivery in these regions, from 2012 to 2022 (forecast).

United States Microneedles for Trans / Intradermal Drug Delivery market competition by top manufacturers/players, with Microneedles for Trans / Intradermal Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Becton Dickinson
    Nanopass Technologies
    Radius Health
    Clearside Biomedical
    Dr. Prausnitz Group
    Zosano Pharma
    Corium International
    Circassia
    Valeritas, Inc.
    BD Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Solid Microneedles
    Hollow Microneedles
    Dissolvable Microneedles
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Drugs
    Vaccines
    Proteins
    Peptides
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Microneedles for Trans / Intradermal Drug Delivery Market Report 2017
1 Microneedles for Trans / Intradermal Drug Delivery Overview
    1.1 Product Overview and Scope of Microneedles for Trans / Intradermal Drug Delivery
    1.2 Classification of Microneedles for Trans / Intradermal Drug Delivery by Product Category
        1.2.1 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Solid Microneedles
        1.2.4 Hollow Microneedles
        1.2.5 Dissolvable Microneedles
    1.3 United States Microneedles for Trans / Intradermal Drug Delivery Market by Application/End Users
        1.3.1 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Drugs
        1.3.3 Vaccines
        1.3.4 Proteins
        1.3.5 Peptides
        1.3.6 Others
    1.4 United States Microneedles for Trans / Intradermal Drug Delivery Market by Region
        1.4.1 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2012-2022)
        1.4.3 Southwest Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2012-2022)
        1.4.5 New England Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2012-2022)
        1.4.6 The South Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2012-2022)
        1.4.7 The Midwest Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Microneedles for Trans / Intradermal Drug Delivery (2012-2022)
        1.5.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2022)
        1.5.2 United States Microneedles for Trans / Intradermal Drug Delivery Revenue and Growth Rate (2012-2022)

2 United States Microneedles for Trans / Intradermal Drug Delivery Market Competition by Players/Suppliers
    2.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Microneedles for Trans / Intradermal Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Microneedles for Trans / Intradermal Drug Delivery Average Price by Players/Suppliers (2012-2017)
    2.4 United States Microneedles for Trans / Intradermal Drug Delivery Market Competitive Situation and Trends
        2.4.1 United States Microneedles for Trans / Intradermal Drug Delivery Market Concentration Rate
        2.4.2 United States Microneedles for Trans / Intradermal Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Microneedles for Trans / Intradermal Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type

3 United States Microneedles for Trans / Intradermal Drug Delivery Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Region (2012-2017)
    3.2 United States Microneedles for Trans / Intradermal Drug Delivery Revenue and Market Share by Region (2012-2017)
    3.3 United States Microneedles for Trans / Intradermal Drug Delivery Price by Region (2012-2017)

4 United States Microneedles for Trans / Intradermal Drug Delivery Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Microneedles for Trans / Intradermal Drug Delivery Revenue and Market Share by Type (2012-2017)
    4.3 United States Microneedles for Trans / Intradermal Drug Delivery Price by Type (2012-2017)
    4.4 United States Microneedles for Trans / Intradermal Drug Delivery Sales Growth Rate by Type (2012-2017)

5 United States Microneedles for Trans / Intradermal Drug Delivery Sales (Volume) by Application (2012-2017)
    5.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Application (2012-2017)
    5.2 United States Microneedles for Trans / Intradermal Drug Delivery Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Microneedles for Trans / Intradermal Drug Delivery Players/Suppliers Profiles and Sales Data
    6.1 Becton Dickinson
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Nanopass Technologies
        6.2.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Radius Health
        6.3.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Radius Health Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Clearside Biomedical
        6.4.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Dr. Prausnitz Group
        6.5.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Dr. Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Zosano Pharma
        6.6.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Corium International
        6.7.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Corium International Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Circassia
        6.8.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Circassia Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Valeritas, Inc.
        6.9.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Valeritas, Inc. Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 BD Medical
        6.10.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 BD Medical Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Microneedles for Trans / Intradermal Drug Delivery Manufacturing Cost Analysis
    7.1 Microneedles for Trans / Intradermal Drug Delivery Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Microneedles for Trans / Intradermal Drug Delivery

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Microneedles for Trans / Intradermal Drug Delivery Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Microneedles for Trans / Intradermal Drug Delivery Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Microneedles for Trans / Intradermal Drug Delivery Sales Volume Forecast by Type (2017-2022)
    11.3 United States Microneedles for Trans / Intradermal Drug Delivery Sales Volume Forecast by Application (2017-2022)
    11.4 United States Microneedles for Trans / Intradermal Drug Delivery Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer